In my last blog post, I laid out 4 realistic directions for my career that popped up last week that will take my career and my life in completely different directions. I addressed why I wouldn't be post-docing, and I want to address the conundrum of the other science job, which is perhaps non-traditional. I've been interning with a small start-up that is developing a surface coating technology for the past 6 weeks. The details of the job aren't important, but the company is run by chemical engineers who have some great technology, are reasonably well grant-funded (SBIR) and hoping to expand. These are very good signs when looking at a start up. However, grant funds tie your hand a little: NSF doesn't pay anyone more than half time, so everyone at this company is there half time. They have a technician they love who is leaving to go to grad school, and they offered me her position with the opportunity to help write some additional grants/seek investors (I am the business development intern).
Yes, you read that right. Get a part-time wage to take on a monumental (and full time) task. If/when money comes in, I've earned my first promotion. High risk, high reward.
Let's look at the risk first. In principle, I don't have to give up contracting to take this job, but I probably would so that I could do the job well. Taking a job as a tech wouldn't be bad if I were promoted quickly/moved on to another position quickly, but it will be hard to find a job to follow-up that one if I have used my PhD as a tech for any period of time. As I explained to my Dad, would you trust a Physician who worked as a CNA after med school? In particular with the job market here being so tight, I don't need any question marks on my resume. But I am not being paid in equity (lesson learned), and the grant should last at least a year, so there is some stability. I'm unlikely to just abruptly lose my job if the company goes under (which they seem unlikely to do). Oh, and I am not a chemist. For some reason, they aren't really considering the possibility that I might be terrible at this job, and there is no evidence to suggest I won't be. Failing at this job (either as a tech or a grant writer) would be bad for the company and bad for my prospects moving forward.
How about the Reward? Well, getting a chance to write myself as a PI on a grant is not something I thought I would be able to do at this stage of my career. That's a big one- if we get funded, that's awesome, but for many reasons I want experience grant writing. I will also get to learn some cool chemistry techniques (however, given the dismal career prospects for chemists, I'm not sure that's more than an intellectual bonus). Looking for investors could help me expand my network (I'm not sure this is a talent I posses or will develop though- so add that back to risk), should I ever decide I am done being a Chemist. And I can create for myself a position in this company that is young and growing that could really take me places.
There are other perks as well. It would be gratifying to tell my old boss I am working at a start-up, it would make sense to him. I would be working in a cool neighborhood, with cool people, which is something I miss about grad school. I've actually been offered this job. It was all I could do not to say "YES, I'll take it!" when offered the position. Wasn't this what I've been working so hard for??
The two questions I am struggling to answer though, are do I have this kind of appetite for risk, and where does this position take me?
A record of my investigations and foibles in the search for an idyllic career as a scientist.
Showing posts with label entrepreneurship. Show all posts
Showing posts with label entrepreneurship. Show all posts
Tuesday, September 4, 2012
Tuesday, July 17, 2012
Business Development Intern
While I was thinking about productive, lucrative, ways to spend my time, I ran across a whole new arena to spend time in. I'm currently working as the business development intern for Zwittertech, a start-up that can put non-fouling polymers on a variety of surfaces. The technology is fairly well developed, but they are at that strange point in a start-up's life cycle where is it is time to decide what they are going to make, and how that is going to make money.
Before I started working at the C4C, I'd never given much thought to how you convert good ideas (example, cure for the common cold) to profitable businesses (curing colds). At some point, some savvy entrepreneur decides how that idea can make money, and puts all the pieces in place to get it made, on the market and used by people. I'm starting to realize this is a unique problem in biotech- well, not unique but incredibly expensive. Imagine, if you will, trying to turn any assay you developed in grad school into something as reliable as a mini-prep. AND reagents are expensive, AND distribution is monopolized AND your clients are worried about their funding and uninterested in taking a risk on new products. This might explain the stagnant growth of the biotech industry in the last few years.
All that aside, my task for the next few weeks is to help Zwittertech decide on thier first product, of the minimally viable product (MVP). The sooner they can get something on the market that makes some revenue, it will add stability to their balance sheet, which can allow them to develop more of the products they are interested in long-term. To figure out what the MVP is, I am using a text book called The Startup Owner's Manual. I'm developing business canvases, and hope to be moving into customer discovery next week.
Before I started working at the C4C, I'd never given much thought to how you convert good ideas (example, cure for the common cold) to profitable businesses (curing colds). At some point, some savvy entrepreneur decides how that idea can make money, and puts all the pieces in place to get it made, on the market and used by people. I'm starting to realize this is a unique problem in biotech- well, not unique but incredibly expensive. Imagine, if you will, trying to turn any assay you developed in grad school into something as reliable as a mini-prep. AND reagents are expensive, AND distribution is monopolized AND your clients are worried about their funding and uninterested in taking a risk on new products. This might explain the stagnant growth of the biotech industry in the last few years.
All that aside, my task for the next few weeks is to help Zwittertech decide on thier first product, of the minimally viable product (MVP). The sooner they can get something on the market that makes some revenue, it will add stability to their balance sheet, which can allow them to develop more of the products they are interested in long-term. To figure out what the MVP is, I am using a text book called The Startup Owner's Manual. I'm developing business canvases, and hope to be moving into customer discovery next week.
Subscribe to:
Posts (Atom)